Are you Dr. Chan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
98-1079 Moanalua Rd
Laboratory, Pali Momi Medical Center
Aiea, HI 96701Phone+1 808-485-4243Fax+1 808-485-4381
Summary
- Dr. Owen Chan, MD is a board certified pathologist in Aiea, Hawaii. He is currently licensed to practice medicine in Hawaii and California. He is affiliated with Straub Medical Center.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematopathology, 2008 - 2009
- University of California (San Diego) Medical CenterResidency, Pathology-Anatomic and Clinical, 2004 - 2008
- University of Hawaii, John A. Burns School of MedicineClass of 2004
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- HI State Medical License 2010 - 2026
- CA State Medical License Active through 2013
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Clinical Trials
- Carvedilol in Treating Hypoglycemia Unawareness Start of enrollment: 2019 Apr 22
Publications & Presentations
PubMed
- 9 citationsPAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity.Hideki Furuya, Yuka Sasaki, Runpu Chen, Rafael Peres, Kanani Hokutan
Scientific Reports. 2022-07-16 - 19 citationsPhase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T.Tanya B. Dorff, Yosuke Hirasawa, Jared David Acoba, Ian Pagano, David Jon Tamura
Journal for Immunotherapy of Cancer. 2021-08-01 - 21 citationsSafety, Tolerability, and Long-Term Clinical Outcomes of an IL-15 analogue (N-803) Admixed with Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Cancer.Charles J. Rosser, Sergei Tikhonenkov, Jeffrey W. Nix, Owen T. M. Chan, Irina Ianculescu
Oncoimmunology. 2021-05-03